138 related articles for article (PubMed ID: 12517805)
1. Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors.
Tsuiki H; Tnani M; Okamoto I; Kenyon LC; Emlet DR; Holgado-Madruga M; Lanham IS; Joynes CJ; Vo KT; Wong AJ
Cancer Res; 2003 Jan; 63(1):250-5. PubMed ID: 12517805
[TBL] [Abstract][Full Text] [Related]
2. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells.
Cui J; Han SY; Wang C; Su W; Harshyne L; Holgado-Madruga M; Wong AJ
Cancer Res; 2006 Oct; 66(20):10024-31. PubMed ID: 17047065
[TBL] [Abstract][Full Text] [Related]
3. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.
Waetzig V; Czeloth K; Hidding U; Mielke K; Kanzow M; Brecht S; Goetz M; Lucius R; Herdegen T; Hanisch UK
Glia; 2005 May; 50(3):235-46. PubMed ID: 15739188
[TBL] [Abstract][Full Text] [Related]
4. A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons.
Fogarty MP; Downer EJ; Campbell V
Biochem J; 2003 May; 371(Pt 3):789-98. PubMed ID: 12534344
[TBL] [Abstract][Full Text] [Related]
5. Cerebral ischemia provokes a profound exchange of activated JNK isoforms in brain mitochondria.
Zhao Y; Herdegen T
Mol Cell Neurosci; 2009 Jun; 41(2):186-95. PubMed ID: 19289169
[TBL] [Abstract][Full Text] [Related]
6. Elevated JNK activation contributes to the pathogenesis of human brain tumors.
Antonyak MA; Kenyon LC; Godwin AK; James DC; Emlet DR; Okamoto I; Tnani M; Holgado-Madruga M; Moscatello DK; Wong AJ
Oncogene; 2002 Aug; 21(33):5038-46. PubMed ID: 12140754
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes.
Senger DL; Tudan C; Guiot MC; Mazzoni IE; Molenkamp G; LeBlanc R; Antel J; Olivier A; Snipes GJ; Kaplan DR
Cancer Res; 2002 Apr; 62(7):2131-40. PubMed ID: 11929835
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinase phosphatase-1 modulated JNK activation is critical for apoptosis induced by inhibitor of epidermal growth factor receptor-tyrosine kinase.
Takeuchi K; Shin-ya T; Nishio K; Ito F
FEBS J; 2009 Mar; 276(5):1255-65. PubMed ID: 19175673
[TBL] [Abstract][Full Text] [Related]
9. Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain.
Wang Y; Luo W; Reiser G
Biochem J; 2007 Jan; 401(1):65-78. PubMed ID: 16942465
[TBL] [Abstract][Full Text] [Related]
10. Effector peptides from glutathione-S-transferase-pi affect the activation of jun by jun-N-terminal kinase.
Adler V; Pincus MR
Ann Clin Lab Sci; 2004; 34(1):35-46. PubMed ID: 15038666
[TBL] [Abstract][Full Text] [Related]
11. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor.
Givant-Horwitz V; Davidson B; Reich R
Cancer Res; 2004 May; 64(10):3572-9. PubMed ID: 15150114
[TBL] [Abstract][Full Text] [Related]
12. Activation of mitogen-activated protein kinases in hamster brains infected with 263K scrapie agent.
Lee HP; Jun YC; Choi JK; Kim JI; Carp RI; Kim YS
J Neurochem; 2005 Oct; 95(2):584-93. PubMed ID: 16135077
[TBL] [Abstract][Full Text] [Related]
13. c-Jun N-terminal kinase regulates lamellipodial protrusion and cell sheet migration during epithelial wound closure by a gene expression-independent mechanism.
Altan ZM; Fenteany G
Biochem Biophys Res Commun; 2004 Sep; 322(1):56-67. PubMed ID: 15313173
[TBL] [Abstract][Full Text] [Related]
14. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
16. c-JUN N-terminal kinase-1 (JNK1) but not JNK2 or JNK3 is involved in UV signal transduction in human epidermis.
Katagiri C; Negishi K; Hibino T
J Dermatol Sci; 2006 Sep; 43(3):171-9. PubMed ID: 16824735
[TBL] [Abstract][Full Text] [Related]
17. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
[TBL] [Abstract][Full Text] [Related]
18. Bcl-w is expressed in a majority of infiltrative gastric adenocarcinomas and suppresses the cancer cell death by blocking stress-activated protein kinase/c-Jun NH2-terminal kinase activation.
Lee HW; Lee SS; Lee SJ; Um HD
Cancer Res; 2003 Mar; 63(5):1093-100. PubMed ID: 12615727
[TBL] [Abstract][Full Text] [Related]
19. Prevention of TNF-alpha-induced apoptosis in polyamine-depleted IEC-6 cells is mediated through the activation of ERK1/2.
Bhattacharya S; Ray RM; Johnson LR
Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G479-90. PubMed ID: 14563673
[TBL] [Abstract][Full Text] [Related]
20. Involvement of wild-type p53 in radiation-induced c-Jun N-terminal kinase activation in human thyroid cells.
Shklyaev SS; Namba H; Sautin Y; Mitsutake N; Nagayama Y; Ishikawa N; Ito K; Zeki K; Yamashita S
Anticancer Res; 2001; 21(4A):2569-75. PubMed ID: 11724323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
